Search clinical trials for: Proprotein convertase subtilisin/kexin type 9 (PCSK9)
Total 68008 results
-
AmgenTIMI Study GroupCompletedHyperlipidemiaUnited States, Canada, Denmark, Czechia, Hungary
-
AmgenCompleted
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedProteomics | Lipoprotein Metabolism | PCSK9United States
-
Kolding SygehusOdense University Hospital; Vejle HospitalRecruitingHyperlipidemias | Nephrotic SyndromeDenmark
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedProteomics | Lipoprotein Metabolism | PCSK9United States
-
AmgenCompletedHyperlipidemiaUnited States, Denmark, Australia, Belgium, Spain, Finland, Sweden, Canada
-
AmgenCompletedSubjects With Hyperlipidemia, Dyslipidemia and HIV InfectionCanada, France, United States, Belgium, Italy, Spain, Switzerland, United Kingdom, South Africa, Portugal, Australia, Greece, Brazil, Romania, Poland
-
Novartis PharmaceuticalsCompletedHypercholesterolemia | LDL CholesterolUnited States
-
AmgenCompletedSubjects With Hyperlipidemia, DyslipidemiaCanada, Netherlands, United States
-
Xiang XieXinjiang Medical UniversityNot yet recruitingCancer | Atherosclerotic Cardiovascular Disease | ASCVD | Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor
-
GE HealthcareLaboratory Corporation of AmericaCompletedStudy to Determine Dosage of OPTISON in Children Between ≥9 and <18 Years of Age Weighing ≥20 kgUnited States
-
First Affiliated Hospital of Harbin Medical UniversityRecruiting
-
SanofiRegeneron PharmaceuticalsCompletedHypercholesterolemiaUnited States, Austria, Canada, Czech Republic, Denmark, France, Israel, Netherlands, Norway, Russian Federation, South Africa, Spain, Sweden, United Kingdom
-
Nantes University HospitalCompletedAcute Coronary SyndromeFrance
-
University Hospital, GrenobleRecruiting
-
AmgenCompletedHyperlipidemiaUnited States, Denmark, Australia, Belgium, Canada
-
Shanghai Tong Ren HospitalRecruitingEarly PCSK9 Inhibitor on Ventricular RemodlingChina
-
Beijing Anzhen HospitalBeijing Municipal Health CommissionNot yet recruiting
-
Hong Kong Baptist UniversityThe Hong Kong Jockey Club Charities TrustCompletedNine Body ConstitutionsChina
-
AmgenCompletedHeterozygous Familial HypercholesterolemiaUnited States, Canada, Italy, Norway, Belgium, Turkey, Australia, New Zealand, Austria, Czechia, South Africa, Poland, Spain, Switzerland, Netherlands, Taiwan, Finland, Brazil, Portugal, Slovenia, Russian Federation, Hungary, United... and more
-
University of California, Los AngelesWithdrawn7-dose Control - Progressive Muscle Relaxation Only | 5-dose - Pairs Progressive Muscle Relaxation With Fruit 5 Consecutive Days | 7-dose - Pairs Progressive Muscle Relaxation With Fruit 7 Consecutive Days | 9-dose - Pairs Progressive Muscle Relaxation With Fruit 9 Consecutive Days
-
Shenzhen People's HospitalRecruitingCardiovascular Diseases | Lipid MetabolismChina
-
Shenzhen People's HospitalRecruitingEvaluate the Efficacy and Safety of IBI306 in Subjects With Homozygous Familial HypercholesterolemiaLipid Metabolism Disorders | Familial Hypercholesterolemia - Homozygous | Proprotein Convertase Subtilisin/Kexin 9China
-
Franck BoccaraInstitut National de la Santé Et de la Recherche Médicale, France; Amgen; National...CompletedDyslipidemias | HIV Seropositivity | PCSK9France
-
LIB Therapeutics LLCMedpace, Inc.Enrolling by invitationFamilial Hypercholesterolemia | Elevated Cholesterol | Cardiovascular Disease With Mention of ArteriosclerosisUnited States, Israel, Norway, South Africa, Turkey, India
-
National Cardiovascular Center Harapan Kita Hospital...Completed
-
LIB Therapeutics LLCMedpace, Inc.CompletedHeterozygous Familial HypercholesterolemiaUnited States, Israel, Norway, South Africa, Turkey
-
Seoul National University HospitalUnknown
-
Dokuz Eylul UniversityEge UniversityCompletedMMP9 | TIMP1 | MMP9 -1562 C/T | TIMP1 372 T/CTurkey
-
Rennes University HospitalRecruitingBlood Concentrations of Nine Anti-cancer Drugs : Axitinib, Olaparib, regorafénib, Cabozantinib, Niraparib, Talazoparib, Palbociclib, Abemaciclib, TucatinibFrance
-
Institut de Recherches Cliniques de MontrealCanadian Institutes of Health Research (CIHR)RecruitingInflammation | Type 2 Diabetes | Insulin Sensitivity/Resistance | Fatty Acids, Omega-3Canada
-
Laval UniversityCompletedFamilial HypercholesterolemiaCanada
-
Shenzhen People's HospitalInnovent Biopharmaceutical Co., Ltd.Active, not recruitingEfficacy and Safety | Heterozygous Familial Hypercholesterolemia | PCSK9China
-
Ludwig-Maximilians - University of MunichGerman Research Foundation; Philipps University Marburg Medical CenterCompletedDigestive Physiology | Gastrointestinal Motility | Gastrointestinal Hormones | Glucagon-like Peptide 1 | Exendin (9-39)Germany
-
Maastricht University Medical CenterRecruitingPost-Infarction Heart Rupture | Gene PolymorphismItaly
-
LIB Therapeutics LLCCompletedHomozygous Familial HypercholesterolemiaUnited States, Israel, Norway, South Africa, Turkey, India
-
BioChain (Beijing) Science and Technology, Inc.Beijing 302 Hospital; Chinese PLA General Hospital; 309th Hospital of Chinese... and other collaboratorsUnknown
-
Instituto de Seguridad y Servicios Sociales de...CompletedHypercholesterolemia, FamilialMexico
-
LIB Therapeutics LLCMedpace, Inc.Active, not recruitingCardiovascular Diseases | Hypercholesterolemia | Cardiovascular Risk Factor | Cardiovascular StrokeUnited States, Israel, India
-
LIB Therapeutics LLCMedpace, Inc.Active, not recruitingCardiovascular Diseases | Hyper-LDL-cholesterolemiaUnited States
-
Tianjin Chest HospitalRecruitingAcute Coronary Syndrome | Proprotein Convertase Subtilisin/Kexin Type 9 InhibitorChina
-
BioChain (Beijing) Science and Technology, Inc.Peking Union Medical College Hospital; Cancer Institute and Hospital, Chinese... and other collaboratorsCompletedColorectal Cancer | Polyps | Adenomatous Polyp of Colon | Other Cancers | Other Disease/InjuryChina
-
9 Meters Biopharma, Inc.TerminatedShort Bowel SyndromeUnited States
-
9 Meters Biopharma, Inc.TerminatedCeliac DiseaseUnited States
-
9 Meters Biopharma, Inc.CompletedCeliac DiseaseUnited States, Canada
-
9 Meters Biopharma, Inc.CompletedCeliac DiseaseCanada, United States
-
9 Meters Biopharma, Inc.CompletedCeliac DiseaseUnited States
-
University of Alabama at BirminghamMerck Investigator Studies ProgramNot yet recruiting
-
Peter S. Liang, MD MPHCompletedColorectal CancerUnited States
-
Buddhist Tzu Chi General HospitalRecruitingDLQI | PHQ-9 | PSAI | Serum Cytokine SurveyTaiwan